BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 31792668)

  • 1. Prolactinomas in pregnancy: considerations before conception and during pregnancy.
    Glezer A; Bronstein MD
    Pituitary; 2020 Feb; 23(1):65-69. PubMed ID: 31792668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactinomas: how to handle prior to and during pregnancy?
    Glezer A; Bronstein MD
    Minerva Endocrinol; 2018 Dec; 43(4):423-429. PubMed ID: 29265784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactinomas and pregnancy.
    Bronstein MD
    Pituitary; 2005; 8(1):31-8. PubMed ID: 16411066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Prolactinoma.
    Inder WJ; Jang C
    Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Update on endocrinology: management of prolactinomas during pregnancy].
    Cecenarro LA; Estario P; Estario ME; Fux-Otta C
    Rev Fac Cien Med Univ Nac Cordoba; 2015; 72(3):170-4. PubMed ID: 26913801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and drug therapy of prolactinoma.
    Ciccarelli E; Camanni F
    Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of prolactinomas: a survey of physicians from the Middle East and North Africa.
    Beshyah SA; Sherif IH; Chentli F; Hamrahian A; Khalil AB; Raef H; El-Fikki M; Jambart S
    Pituitary; 2017 Apr; 20(2):231-240. PubMed ID: 27783196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas.
    Ono M; Miki N; Amano K; Kawamata T; Seki T; Makino R; Takano K; Izumi S; Okada Y; Hori T
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2672-9. PubMed ID: 20357175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current approach to treatments for prolactinomas.
    Tirosh A; Shimon I
    Minerva Endocrinol; 2016 Sep; 41(3):316-23. PubMed ID: 26399371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactinoma and pregnancy: From the wish of conception to lactation.
    Maiter D
    Ann Endocrinol (Paris); 2016 Jun; 77(2):128-34. PubMed ID: 27130071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoplexy of microprolactinomas during pregnancy: report of five cases and review of the literature.
    Kuhn E; Weinreich AA; Biermasz NR; Jorgensen JOL; Chanson P
    Eur J Endocrinol; 2021 May; 185(1):99-108. PubMed ID: 33914699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical treatment of prolactinomas.
    Molitch ME
    Endocrinol Metab Clin North Am; 1999 Mar; 28(1):143-69, vii. PubMed ID: 10207689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperprolactinemia: pathophysiology and management.
    Verhelst J; Abs R
    Treat Endocrinol; 2003; 2(1):23-32. PubMed ID: 15871552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dopamine-agonist resistant prolactinomas: diagnosis and management].
    Musolino NR; Passos VQ
    Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):641-50. PubMed ID: 16444347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactinomas, cabergoline, and pregnancy.
    Glezer A; Bronstein MD
    Endocrine; 2014 Sep; 47(1):64-9. PubMed ID: 24985062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prolactinoma].
    Glezer A; Bronstein MD
    Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):118-23. PubMed ID: 24830588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine receptor agonists for treating prolactinomas.
    Colao A; di Sarno A; Pivonello R; di Somma C; Lombardi G
    Expert Opin Investig Drugs; 2002 Jun; 11(6):787-800. PubMed ID: 12036422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactinomas resistant to bromocriptine: long-term efficacy of quinagolide and outcome of pregnancy.
    Morange I; Barlier A; Pellegrini I; Brue T; Enjalbert A; Jaquet P
    Eur J Endocrinol; 1996 Oct; 135(4):413-20. PubMed ID: 8921822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine agonists and pituitary tumor shrinkage.
    Bevan JS; Webster J; Burke CW; Scanlon MF
    Endocr Rev; 1992 May; 13(2):220-40. PubMed ID: 1352243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on prolactinomas. Part 2: Treatment and management strategies.
    Wong A; Eloy JA; Couldwell WT; Liu JK
    J Clin Neurosci; 2015 Oct; 22(10):1568-74. PubMed ID: 26243714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.